About
PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
- Name
- Invesco Biotechnology & Genome ETF
- Index tracked
- Dynamic Biotech&Genome Intellidex TR USD
- Type
- Equity
- Expense ratio
- 0.59%
- Management fee
- 0.5%
- Dividend policy
- Quarterly
- NAV
- USD 93.36 (09/16/2026)
- Issued units
- 4.36M (09/17/2026)
- Listing date
- Jun 23, 2005
- Sponsor
- Invesco
- Custodian
- The Bank of New York Mellon